enGene Ownership | Who Owns enGene?
enGene Ownership Summary
enGene is owned by 79.98% institutional investors, 0.32% insiders, and 19.70% retail investors. Fcpm iii services b.v. is the largest institutional shareholder, holding 18.85% of ENGN shares.
ENGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | enGene | 79.98% | 0.32% | 19.70% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 9.63M | 18.85% | $65.79M |
| Vr adviser | 5.05M | 9.88% | $34.47M |
| Kynam capital management, lp | 4.99M | 9.77% | $34.11M |
| Blue owl capital lp | 3.28M | 6.42% | $22.39M |
| Cormorant asset management, lp | 2.32M | 4.55% | $15.87M |
| Braidwell lp | 2.27M | 4.44% | $15.48M |
| Deep track capital, lp | 2.24M | 4.38% | $15.29M |
| Perceptive advisors | 2.10M | 4.10% | $14.32M |
| Point72 asset management | 1.21M | 2.36% | $8.25M |
| Frazier life sciences management | 1.16M | 2.27% | $7.90M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 9.63M | 13.15% | $65.79M |
| Blue owl capital lp | 3.28M | 6.95% | $22.39M |
| Kynam capital management, lp | 4.99M | 2.54% | $34.11M |
| Vr adviser | 5.05M | 1.94% | $34.47M |
| Omega fund management | 526.36K | 1.62% | $3.60M |
| Cormorant asset management, lp | 2.32M | 1.10% | $15.87M |
| Sr one capital management, lp | 747.75K | 0.74% | $5.11M |
| Sphera funds management | 504.41K | 0.73% | $3.45M |
| Bioimpact capital | 530.30K | 0.59% | $3.62M |
| Braidwell lp | 2.27M | 0.46% | $15.48M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | 2.27M | 0.46% | 2.27M |
| Perceptive advisors | 2.10M | 0.41% | 2.10M |
| Frazier life sciences management | 1.16M | 0.24% | 1.16M |
| Bioimpact capital | 530.30K | 0.59% | 530.30K |
| Morgan stanley | 435.29K | 0.00% | 82.52K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 2.24M | 0.43% | -2.32M |
| Goldman sachs group | 147.60K | 0.00% | -751.48K |
| Orbimed advisors | - | - | -677.98K |
| Blue owl capital lp | 3.28M | 6.95% | -450.00K |
| Schonfeld strategic advisors | 25.07K | 0.00% | -149.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Braidwell lp | 2.27M | 0.46% | 2.27M | $15.48M |
| Perceptive advisors | 2.10M | 0.41% | 2.10M | $14.32M |
| Frazier life sciences management | 1.16M | 0.24% | 1.16M | $7.90M |
| Bioimpact capital | 530.30K | 0.59% | 530.30K | $3.62M |
| Hudson bay capital management lp | 11.07K | 0.00% | 11.07K | $75.64K |
Sold Out
| Holder | Change |
|---|---|
| Nbc securities | -380.00 |
| Ubs group | -1.20K |
| Wolverine asset management | -6.36K |
| Paloma partners management | -10.32K |
| Renaissance | -11.40K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 38 | 2.70% | 40,868,497 | 1.11% | 79 | 1.27% | 14 | 7.69% | 8 | -11.11% |
| Jun 30, 2025 | 37 | 19.35% | 40,420,485 | -1.27% | 79 | 1.23% | 13 | 44.44% | 9 | 12.50% |
| Mar 31, 2025 | 31 | -8.82% | 40,941,351 | -0.88% | 80 | 1.22% | 9 | -59.09% | 8 | 14.29% |
| Dec 31, 2024 | 34 | 13.33% | 41,304,528 | 20.44% | 81 | 1.34% | 22 | 37.50% | 7 | 75.00% |
| Sep 30, 2024 | 30 | - | 34,293,391 | 5.17% | 77 | 1.42% | 16 | 14.29% | 4 | -33.33% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.00M |
| Oct 07, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $77.53K |
| Oct 04, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $39.24K |
| Oct 03, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $37.40K |
| Oct 08, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 7 | - |
| 2024 Q3 | 4 | - |
ENGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools